Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96 ‐week results from two randomized clinical trials

HIV Medicine, EarlyView.

Source: HIV Medicine - August 13, 2018 Category: Infectious Diseases Authors: D Hagins , C Orkin , ES Daar , A Mills , C Brinson , E DeJesus , FA Post , J Morales ‐Ramirez , M Thompson , O Osiyemi , B Rashbaum , H‐J Stellbrink , C Martorell , H Liu , Y‐P Liu , D Porter , SE Collins , D SenG Source Type: research